1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Bin Gu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease Gecacitinib-Corticosteroid, Methylprednisolone sodium succinate - aGVHD | Phase 2 | Recruiting | Bin Gu | 25 | 2026-01-01 | 2026-09-23 |
Methylprednisolone Hemisuccinate (1)
China (1)